# A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults

> **NCT00474487** · PHASE3 · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 2831 (actual)

## Conditions studied

- Meningococcal Meningitis
- Meningococcal Infections

## Interventions

- **BIOLOGICAL:** Meningococcal ACWY Polysaccharide Vaccine
- **BIOLOGICAL:** MenACWY CRM (19 to 55 years)
- **BIOLOGICAL:** Meningococcal ACWY Conjugate Vaccine
- **BIOLOGICAL:** Novartis MenACWY Vaccine (56 to 65 Years)

## Key facts

- **NCT ID:** NCT00474487
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-08
- **Final completion:** 2008-02
- **Target enrollment:** 2831 (ACTUAL)
- **Last updated:** 2014-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00474487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00474487, "A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Healthy Adults". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00474487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*